SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (759)3/6/2000 12:34:00 AM
From: Vector1  Read Replies (1) | Respond to of 52153
 
MRK may be a bit of a challenge but there are some smaller pharma and drug delivery companies that might be worth lets say a Millenium picking up. HGSI is less likely to be able to pull it off because they are not as well respected and Hazeltine has a reputation for being difficult to get along with. Drug delivery is a particularly interesting angle and may be a nice fit with a MLNM. Elan comes to mind.

V1